☰

Ryan P. Abo, Ph.D. - Publications

Affiliations: 
2010 Biomedical Informatics University of Utah, Salt Lake City, UT 
Area:
Genetics, Epidemiology, Statistics
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Vasbinder MM, Gozgit JM, Abo RP, Kunii K, Kuplast-Barr KG, Gui B, Lu AZ, Swinger KK, Wigle TJ, Blackwell DJ, Majer CR, Ren Y, Niepel M, Varsamis ZA, Nayak SP, et al. Abstract DDT02-01: RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways Cancer Research. 80. DOI: 10.1158/1538-7445.Am2020-Ddt02-01  0.329
2016 Niu N, Liu T, Cairns J, Ly RC, Tan X, Deng M, Fridley BL, Kalari KR, Abo RP, Jenkins G, Batzler A, Carlson EE, Barman P, Moran S, Heyn H, et al. Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines. Human Molecular Genetics. 25: 4819-4834. PMID 28173075 DOI: 10.1093/Hmg/Ddw301  0.364
2016 Niu N, Liu T, Cairns J, Ly RC, Tan X, Deng M, Fridley BL, Kalari KR, Abo RP, Jenkins G, Batzler A, Carlson EE, Barman P, Moran S, Heyn H, et al. Metformin Pharmacogenomics: A genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines. Human Molecular Genetics. PMID 27616566 DOI: 10.1093/hmg/ddw301  0.366
2016 Camp NJ, Lin WY, Bigelow A, Burghel GJ, Mosbruger T, Parry M, Waller RG, Rigas SH, Tai PY, Berrett K, Rajamanickam V, Cosby R, Brock IW, Jones B, Connley D, ... ... Abo R, et al. Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Research. PMID 26795348 DOI: 10.1158/0008-5472.Can-15-1629  0.63
2016 Chapuy B, Cheng H, Watahiki A, Ducar MD, Tan Y, Chen L, Roemer MG, Ouyang J, Christie AL, Zhang L, Gusenleitner D, Abo RP, Farinha P, von Bonin F, Thorner AR, et al. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biologic heterogeneity of the disease. Blood. PMID 26773040 DOI: 10.1182/Blood-2015-09-672352  0.317
2015 Chapuy B, Roemer MG, Stewart C, Tan Y, Abo RP, Zhang L, Dunford AJ, Meredith DM, Thorner AR, Jordanova ES, Liu G, Feuerhake F, Ducar MD, Illerhaus G, Gusenleitner D, et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. PMID 26702065 DOI: 10.1182/Blood-2015-10-673236  0.338
2015 Abo RP, Ducar M, Garcia EP, Thorner AR, Rojas-Rudilla V, Lin L, Sholl LM, Hahn WC, Meyerson M, Lindeman NI, Van Hummelen P, MacConaill LE. BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers. Nucleic Acids Research. 43: e19. PMID 25428359 DOI: 10.1093/Nar/Gku1211  0.344
2015 Abo RP, Lin L, Hunter SS, Dolcen DN, Paquette RR, Laing A, Waal Ld, Thorner AR, Ducar MD, Ziaugra L, Hahn WC, Meyerson ML, MacConaill LE, Hummelen PV. Abstract 4867: Comparative analysis of RNA sequencing methods for characterization of cancer transcriptomics Cancer Research. 75: 4867-4867. DOI: 10.1158/1538-7445.Am2015-4867  0.348
2015 Garcia EP, Ligon AH, Abo RP, Cin PSD, Weremowicz S, Shivdasani P, Davineni PK, Zepf DL, Ducar MD, Hummelen PV, Jia Y, Kuo FC, Sholl LM, MacConaill LE, Lindeman NI. Abstract 2991: Detection of gene rearrangements using OncoPanel: a targeted next-generation sequencing assay Cancer Research. 75: 2991-2991. DOI: 10.1158/1538-7445.Am2015-2991  0.42
2015 Lin L, Abo R, Dolcen D, Paquette R, Laing A, Waal Ld, Thorner A, Ducar M, Ziaugra L, Wollison B, Breneiser M, Hahn W, Meyerson M, Hummelen PV, MacConaill L. Abstract 1115: Targeted RNA sequencing improves transcript analysis in cancer samples Cancer Research. 75: 1115-1115. DOI: 10.1158/1538-7445.Am2015-1115  0.332
2014 Li L, Fridley BL, Kalari K, Niu N, Jenkins G, Batzler A, Abo RP, Schaid D, Wang L. Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines Bmc Genomics. 15. PMID 24483146 DOI: 10.1186/1471-2164-15-93  0.401
2014 Fridley BL, Abo R, Tan XL, Jenkins GD, Batzler A, Moyer AM, Biernacka JM, Wang L. Integrative gene set analysis: Application to platinum pharmacogenomics Omics a Journal of Integrative Biology. 18: 34-41. PMID 24199607 DOI: 10.1089/Omi.2013.0099  0.334
2014 Abo RP, Garcia EP, Ducar M, Adusumilli R, Breneiser M, Rojas-Rudilla V, Sholl LM, Lindeman NI, Meyerson ML, Hahn WC, Hummelen PV, MacConaill LE. Abstract 5321: BreaKmer: Detection of structural rearrangements in targeted next-generation sequencing data using kmers Cancer Research. 74: 5321-5321. DOI: 10.1158/1538-7445.Am2014-5321  0.389
2013 Jiang J, Fridley BL, Feng Q, Abo RP, Brisbin A, Batzler A, Jenkins G, Long PA, Wang L. Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system. Frontiers in Genetics. 4: 166. PMID 24009623 DOI: 10.3389/Fgene.2013.00166  0.444
2013 Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L. Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. Plos One. 8: e70216. PMID 23936393 DOI: 10.1371/Journal.Pone.0070216  0.311
2013 Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A, Biernacka JM, Abo R, Brisbin A, Ji Y, Hebbring S, Wieben ED, Mrazek DA, Weinshilboum RM, Wang L. FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogenetics and Genomics. 23: 156-66. PMID 23324805 DOI: 10.1097/Fpc.0B013E32835Dc133  0.448
2013 Niu N, Tan X, Fridley BL, Schaid DJ, Abo RP, Batzler A, Carlson EE, Jenkins G, Moran S, Heyn HA, Badosa ME, Wang L. Abstract 2271: Metformin pharmacogenomics: A genome-wide associate study to identify genetic and epigenetic biomarkers involved in metformin response. Cancer Research. 73: 2271-2271. DOI: 10.1158/1538-7445.Am2013-2271  0.4
2013 Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L. Abstract 2209: Contribution ofFKBP5genetic variation to gemcitabine treatment and survival in pancreatic cancer. Cancer Research. 73: 2209-2209. DOI: 10.1158/1538-7445.Am2013-2209  0.445
2012 Niu N, Schaid DJ, Abo RP, Kalari K, Fridley BL, Feng Q, Jenkins G, Batzler A, Brisbin AG, Cunningham JM, Li L, Sun Z, Yang P, Wang L. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study. Bmc Cancer. 12: 422. PMID 23006423 DOI: 10.1186/1471-2407-12-422  0.445
2012 Knight S, Abo RP, Abel HJ, Neklason DW, Tuohy TM, Burt RW, Thomas A, Camp NJ. Shared genomic segment analysis: the power to find rare disease variants. Annals of Human Genetics. 76: 500-9. PMID 22989048 DOI: 10.1111/J.1469-1809.2012.00728.X  0.58
2012 Abo R, Jenkins GD, Wang L, Fridley BL. Identifying the genetic variation of gene expression using gene sets: application of novel gene Set eQTL approach to PharmGKB and KEGG. Plos One. 7: e43301. PMID 22905253 DOI: 10.1371/Journal.Pone.0043301  0.441
2012 Ji Y, Nordgren KK, Chai Y, Hebbring SJ, Jenkins GD, Abo RP, Peng Y, Pelleymounter LL, Moon I, Eckloff BW, Chai X, Zhang J, Fridley BL, Yee VC, Wieben ED, et al. Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 1984-92. PMID 22807109 DOI: 10.1124/Dmd.112.046953  0.415
2012 Chalise P, Batzler A, Abo R, Wang L, Fridley BL. Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis. Omics : a Journal of Integrative Biology. 16: 363-73. PMID 22734853 DOI: 10.1089/Omi.2011.0126  0.385
2012 Abo R, Hebbring S, Ji Y, Zhu H, Zeng ZB, Batzler A, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Fridley B, Schaid D, Kamatani N, Nakamura Y, et al. Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics. Pharmacogenetics and Genomics. 22: 247-53. PMID 22322242 DOI: 10.1097/Fpc.0B013E32835001C9  0.462
2012 Hebbring SJ, Chai Y, Ji Y, Abo RP, Jenkins GD, Fridley B, Zhang J, Eckloff BW, Wieben ED, Weinshilboum RM. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization. Journal of Neurochemistry. 120: 881-90. PMID 22220685 DOI: 10.1111/J.1471-4159.2012.07646.X  0.459
2012 Li L, Schaid DJ, Fridley BL, Kalari KR, Jenkins GD, Abo RP, Batzler A, Moon I, Pelleymounter L, Eckloff BW, Wieben ED, Sun Z, Yang P, Wang L. Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer. Pharmacogenetics and Genomics. 22: 105-16. PMID 22173087 DOI: 10.1097/Fpc.0B013E32834Dd7E2  0.401
2012 Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MW, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A. Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 176-81. PMID 22056502 DOI: 10.1158/1055-9965.Epi-11-0845  0.614
2011 Pelleymounter LL, Moon I, Johnson JA, Laederach A, Halvorsen M, Eckloff B, Abo R, Rossetti S. A novel application of pattern recognition for accurate SNP and indel discovery from high-throughput data: targeted resequencing of the glucocorticoid receptor co-chaperone FKBP5 in a Caucasian population. Molecular Genetics and Metabolism. 104: 457-69. PMID 21917492 DOI: 10.1016/J.Ymgme.2011.08.019  0.458
2011 Nordgren KK, Peng Y, Pelleymounter LL, Moon I, Abo R, Feng Q, Eckloff B, Yee VC, Wieben E, Weinshilboum RM. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 2135-47. PMID 21813468 DOI: 10.1124/Dmd.111.040857  0.45
2011 Tan XL, Moyer AM, Fridley BL, Schaid DJ, Niu N, Batzler AJ, Jenkins GD, Abo RP, Li L, Cunningham JM, Sun Z, Yang P, Wang L. Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5801-11. PMID 21775533 DOI: 10.1158/1078-0432.Ccr-11-1133  0.44
2011 Feng Q, Kalari K, Fridley BL, Jenkins G, Ji Y, Abo R, Hebbring S, Zhang J, Nye MD, Leeder JS, Weinshilboum RM. Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlation. Molecular Genetics and Metabolism. 102: 126-33. PMID 21093336 DOI: 10.1016/J.Ymgme.2010.10.010  0.401
2011 Abo R, Knight S, Thomas A, Camp NJ. Automated construction and testing of multi-locus gene-gene associations. Bioinformatics (Oxford, England). 27: 134-6. PMID 21076150 DOI: 10.1093/Bioinformatics/Btq616  0.605
2010 Abo R, Wong J, Thomas A, Camp NJ. Haplotype association analyses in resources of mixed structure using Monte Carlo testing. Bmc Bioinformatics. 11: 592. PMID 21143908 DOI: 10.1186/1471-2105-11-592  0.614
2010 Curtin K, Wolff RK, Herrick JS, Abo R, Slattery ML. Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor Bmc Medical Genetics. 11: 170-170. PMID 21129206 DOI: 10.1186/1471-2350-11-170  0.529
2010 Abo RP, Parry M, Rigas SH, Cox A, Camp NJ. Abstract 2844: Association of genetic variants in TNFRSF10B and breast cancer Cancer Research. 70: 2844-2844. DOI: 10.1158/1538-7445.Am10-2844  0.659
2010 Parry M, Elliott G, Abo R, Camp NJ, Neal DE, Donovan JL, Hamdy FC, Cox A. Abstract 2843: Caspase-8 gene SNPs in prostate cancer susceptibility: a replication study Cancer Research. 70: 2843-2843. DOI: 10.1158/1538-7445.Am10-2843  0.605
2009 Piccolo SR, Abo RP, Allen-Brady K, Camp NJ, Knight S, Anderson JL, Horne BD. Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study. Bmc Proceedings. 3: S46. PMID 20018038 DOI: 10.1186/1753-6561-3-S7-S46  0.665
2009 Knight S, Abo RP, Wong J, Thomas A, Camp NJ. Pedigree association: assigning individual weights to pedigree members for genetic association analysis. Bmc Proceedings. 3: S121. PMID 20017987 DOI: 10.1186/1753-6561-3-S7-S121  0.552
2009 Shephard ND, Abo R, Rigas SH, Frank B, Lin WY, Brock IW, Shippen A, Balasubramanian SP, Reed MW, Bartram CR, Meindl A, Schmutzler RK, Engel C, Burwinkel B, Cannon-Albright LA, et al. A breast cancer risk haplotype in the caspase-8 gene. Cancer Research. 69: 2724-8. PMID 19318553 DOI: 10.1158/0008-5472.Can-08-4266  0.701
2008 Abo R, Knight S, Wong J, Cox A, Camp NJ. hapConstructor: automatic construction and testing of haplotypes in a Monte Carlo framework. Bioinformatics (Oxford, England). 24: 2105-7. PMID 18653522 DOI: 10.1093/Bioinformatics/Btn359  0.622
Show low-probability matches.